ロード中...
RTL551 Treatment of EAE Reduces CD226 and T-bet+ CD4 T Cells in Periphery and Prevents Infiltration of T-bet+ IL-17, IFN-γ Producing T Cells into CNS
Recombinant T cell receptor ligands (RTLs) that target encephalitogenic T-cells can reverse clinical and histological signs of EAE, and are currently in clinical trials for treatment of multiple sclerosis. To evaluate possible regulatory mechanisms, we tested effects of RTL therapy on expression of...
保存先:
主要な著者: | , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Public Library of Science
2011
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3130056/ https://ncbi.nlm.nih.gov/pubmed/21750737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0021868 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|